Ergebnis für "Bad Blood" in Ökonomie

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion.

The most urgent story in modern tech begins not in Silicon Valley but two hundred years ago in rural England, when workers known as the Luddites rose up rather than starve at the hands of factory owners who were using automated machines to erase their livelihoods. The Luddites organized guerrilla raids to smash those machines—on punishment of death—and won the support of Lord Byron, enraged the Prince Regent, and inspired the birth of science fiction. This all-but-forgotten class struggle brought nineteenth-century England to its knees.

Journalist Kathleen McLaughlin knew she’d found a treatment that worked on her rare autoimmune disorder. She had no idea it had been drawn from the veins of America’s most vulnerable. So begins McLaughlin’s ten-year investigation researching and reporting on the $20-billion-a year business she found at the other end of her medication, revealing a “vampiric real-life story of modern-day greed” (Leah Sottile, host of Bundyville).